H.C. Wainwright Reiterates Buy Rating on Avidity Biosciences (RNA)

June 10, 2025 6:40 AM UTC Send to a Friend
H.C. Wainwright analyst Ananda Ghosh reiterated a Buy rating and $68.00 price target on Avidity Biosciences (NASDAQ: RNA).The analyst commented ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login